Skip to content
Governance Register

← US public companies

Claiborne Cary J

SEC-identified person · CIK 1370930 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Adial Pharmaceuticals, INC. ADIL Director · Chief Operating Officer filed 2021–2026
Neurosense Therapeutics Ltd. NRSN Director filed 2026–2026
Ladrx Corp cytr Director filed 2022–2024
Sucampo Pharmaceuticals, Inc. SCMP Chief financial officer filed 2011–2014
Wireless Holdings INC WLHO.OB Director · former CEO, CFO & Pres. filed 2008–2011
Osiris Therapeutics, INC. OSIR Chief Financial Officer filed 2006–2007

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.